Episode

Liver Lineup: Navigating Hepatitis B Prevention After ACIP’s Birth Dose Shift

Podcast
HCPLive Podcasts
Published
Feb 4, 2026
Duration seconds
832
Processing state
not_requested
Canonical source
https://audioboom.com/posts/8856830
Audio
https://audioboom.com/posts/8856830.mp3?modified=1770214553&sid=5004077&source=rss
JSON
/v1/public/podcasts/hcplive-podcasts-19526/episodes/liver-lineup-navigating-hepatitis-b-prevention-after-acip-s-birth-dose-shift
Markdown
/podcast/hcplive-podcasts-19526/liver-lineup-navigating-hepatitis-b-prevention-after-acip-s-birth-dose-shift.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/hcplive-podcasts-19526/episodes/liver-lineup-navigating-hepatitis-b-prevention-after-acip-s-birth-dose-shift/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/hcplive-podcasts-19526/liver-lineup-navigating-hepatitis-b-prevention-after-acip-s-birth-dose-shift.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of Liver Lineup: Updates & Unfiltered Insights, hosts Nancy Reau, MD, and Kim Brown, MD, take on a recent consequential and controversial public health decision: the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices’ (ACIP) vote to remove the universal birth-dose hepatitis B vaccine recommendation for infants born to mothers who test negative for HBV. Key episode timestamps: 0:00:00 – Introduction and initial reactions 0:01:40 – Hep B as an anti‑cancer vaccine & global perspective 0:03:59 – Transmission, testing gaps, and implementation problems 0:07:48 – Infant risk, carrier status, and long‑term protection 0:10:14 – Broader health and oncology implications 0:11:48 – Personal stance and closing thoughts